1h Free Analyst Time
The penicillin market is forecasted to grow by USD 2.82 bn during 2023-2028, accelerating at a CAGR of 5.4% during the forecast period. The report on the penicillin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases, growing awareness of various diseases and their treatment, and special regulatory designations driving the quality of penicillin.
The penicillin market is segmented as below:
By Source
- Semisynthetic
- Natural
By Type
- Oral
- Parenteral
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the penicillin market covers the following areas:
- Penicillin market sizing
- Penicillin market forecast
- Penicillin market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Source
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global penicillin market: Abbott Laboratories, AdvaCare Pharma, Aenova Holding GmbH, Astellas Pharma Inc., Canvax Biotech SL, Cipla Ltd., F. Hoffmann La Roche Ltd., Fermenta Biotech Ltd., Focus Technology Co. Ltd., FUJIFILM Corp., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Lupin Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Recipharm AB, Sanofi SA, Viatris Inc., and Wellona Pharma.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic alliances and M and A among penicillin vendors."
According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AdvaCare Pharma
- Aenova Holding GmbH
- Astellas Pharma Inc.
- Canvax Biotech SL
- Cipla Ltd.
- F. Hoffmann La Roche Ltd.
- Fermenta Biotech Ltd.
- Focus Technology Co. Ltd.
- FUJIFILM Corp.
- GlaxoSmithKline Plc
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Recipharm AB
- Sanofi SA
- Viatris Inc.
- Wellona Pharma
